Amalgamated Bank Protalix Bio Therapeutics, Inc. Transaction History
Amalgamated Bank
- $13.6 Billion
- Q3 2025
A detailed history of Amalgamated Bank transactions in Protalix Bio Therapeutics, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 2,381 shares of PLX stock, worth $5,071. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,381
Previous 2,381
-0.0%
Holding current value
$5,071
Previous $3,000
66.67%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding PLX
# of Institutions
69Shares Held
8.7MCall Options Held
168KPut Options Held
31.4K-
Jim Simons Renaissance Technologies LLC | New York, Ny1.62MShares$3.44 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL1.08MShares$2.3 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA820KShares$1.75 Million0.0% of portfolio
-
Stratos Wealth Partners, Ltd.500KShares$1.07 Million0.01% of portfolio
-
Connor, Clark & Lunn Investment Management Ltd.496KShares$1.06 Million0.0% of portfolio
About Protalix BioTherapeutics, Inc.
- Ticker PLX
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,753,400
- Market Cap $106M
- Description
- Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...